FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783804430> ?p ?o ?g. }

• W2783804430 endingPage "e0191292" @default.
• W2783804430 startingPage "e0191292" @default.
• W2783804430 abstract "The complement and coagulation systems closely interact with each other. These interactions are believed to contribute to the proinflammatory and prothrombotic environment involved in the development of thrombotic complications in many diseases. Complement MASP-1 (mannan-binding lectin-associated serine protease-1) activates coagulation factors and promotes clot formation. However, this was mainly shown in purified or plasma-based static systems. Here we describe the role of MASP-1 and complement activation in fibrin clot formation in a microvascular, whole blood flow model. This microfluidic system simulates blood flow through microvessels at physiological flow and shear rates and represents the closest model system to human physiology so far. It features parallel microchannels cultured with endothelial cells in a transparent microfluidic chip allowing real-time evaluation of clot formation by confocal microscopy. To test their effects on clot formation, we added the following activators or inhibitors (individually or in combination) to whole blood and performed perfusion experiments: rMASP-1cf (recombinant active form of MASP-1), complement activator zymosan, selective MASP-1 inhibitor SGMI-1 (based on the Schistocerca gregaria protease inhibitor scaffold), classical pathway inhibitor rSALO (recombinant salivary anti-complement from Lutzomyia longipalpis). Addition of rMASP-1cf resulted in accelerated fibrin clot formation while addition of SGMI-1 delayed it. Complement activation by zymosan led to increased clot formation and this effect was partially reversed by addition of rSALO and almost abolished in combination with SGMI-1. We show for the first time a strong influence of MASP-1, complement activation and pathway-specific inhibition on coagulation in a microvascular flow system that is closest to human physiology, further underpinning the in vivo relevance of coagulation and complement interactions." @default.
• W2783804430 created "2018-01-26" @default.
• W2783804430 creator A5024701852 @default.
• W2783804430 creator A5028801295 @default.
• W2783804430 creator A5034766496 @default.
• W2783804430 creator A5051500239 @default.
• W2783804430 creator A5051618397 @default.
• W2783804430 creator A5065031384 @default.
• W2783804430 date "2018-01-11" @default.
• W2783804430 modified "2023-10-03" @default.
• W2783804430 title "MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model" @default.
• W2783804430 cites W1484854422 @default.
• W2783804430 cites W1574595419 @default.
• W2783804430 cites W1843905884 @default.
• W2783804430 cites W1854717184 @default.
• W2783804430 cites W1939603229 @default.
• W2783804430 cites W1963924977 @default.
• W2783804430 cites W1976444953 @default.
• W2783804430 cites W2030345149 @default.
• W2783804430 cites W2034652230 @default.
• W2783804430 cites W2043922211 @default.
• W2783804430 cites W2058241702 @default.
• W2783804430 cites W2066290080 @default.
• W2783804430 cites W2070418993 @default.
• W2783804430 cites W2072426213 @default.
• W2783804430 cites W2082729347 @default.
• W2783804430 cites W2097503680 @default.
• W2783804430 cites W2113038626 @default.
• W2783804430 cites W2114563488 @default.
• W2783804430 cites W2116775934 @default.
• W2783804430 cites W2134766290 @default.
• W2783804430 cites W2138535926 @default.
• W2783804430 cites W2163494154 @default.
• W2783804430 cites W2165859180 @default.
• W2783804430 cites W2166673618 @default.
• W2783804430 cites W2176278444 @default.
• W2783804430 cites W2193203990 @default.
• W2783804430 cites W2272593372 @default.
• W2783804430 cites W2275060683 @default.
• W2783804430 cites W2331901704 @default.
• W2783804430 cites W2466946639 @default.
• W2783804430 cites W2541189331 @default.
• W2783804430 cites W2579706302 @default.
• W2783804430 cites W947075466 @default.
• W2783804430 doi "https://doi.org/10.1371/journal.pone.0191292" @default.
• W2783804430 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5764403" @default.
• W2783804430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29324883" @default.
• W2783804430 hasPublicationYear "2018" @default.
• W2783804430 type Work @default.
• W2783804430 sameAs 2783804430 @default.
• W2783804430 citedByCount "28" @default.
• W2783804430 countsByYear W27838044302018 @default.
• W2783804430 countsByYear W27838044302019 @default.
• W2783804430 countsByYear W27838044302020 @default.
• W2783804430 countsByYear W27838044302021 @default.
• W2783804430 countsByYear W27838044302022 @default.
• W2783804430 countsByYear W27838044302023 @default.
• W2783804430 crossrefType "journal-article" @default.
• W2783804430 hasAuthorship W2783804430A5024701852 @default.
• W2783804430 hasAuthorship W2783804430A5028801295 @default.
• W2783804430 hasAuthorship W2783804430A5034766496 @default.
• W2783804430 hasAuthorship W2783804430A5051500239 @default.
• W2783804430 hasAuthorship W2783804430A5051618397 @default.
• W2783804430 hasAuthorship W2783804430A5065031384 @default.
• W2783804430 hasBestOaLocation W27838044301 @default.
• W2783804430 hasConcept C111684460 @default.
• W2783804430 hasConcept C12554922 @default.
• W2783804430 hasConcept C126322002 @default.
• W2783804430 hasConcept C1621761 @default.
• W2783804430 hasConcept C171279029 @default.
• W2783804430 hasConcept C181199279 @default.
• W2783804430 hasConcept C185592680 @default.
• W2783804430 hasConcept C203014093 @default.
• W2783804430 hasConcept C203880312 @default.
• W2783804430 hasConcept C2776714187 @default.
• W2783804430 hasConcept C2777807008 @default.
• W2783804430 hasConcept C2778382381 @default.
• W2783804430 hasConcept C2779036427 @default.
• W2783804430 hasConcept C54173615 @default.
• W2783804430 hasConcept C55493867 @default.
• W2783804430 hasConcept C71924100 @default.
• W2783804430 hasConcept C86803240 @default.
• W2783804430 hasConcept C8891405 @default.
• W2783804430 hasConcept C95444343 @default.
• W2783804430 hasConceptScore W2783804430C111684460 @default.
• W2783804430 hasConceptScore W2783804430C12554922 @default.
• W2783804430 hasConceptScore W2783804430C126322002 @default.
• W2783804430 hasConceptScore W2783804430C1621761 @default.
• W2783804430 hasConceptScore W2783804430C171279029 @default.
• W2783804430 hasConceptScore W2783804430C181199279 @default.
• W2783804430 hasConceptScore W2783804430C185592680 @default.
• W2783804430 hasConceptScore W2783804430C203014093 @default.
• W2783804430 hasConceptScore W2783804430C203880312 @default.
• W2783804430 hasConceptScore W2783804430C2776714187 @default.
• W2783804430 hasConceptScore W2783804430C2777807008 @default.
• W2783804430 hasConceptScore W2783804430C2778382381 @default.
• W2783804430 hasConceptScore W2783804430C2779036427 @default.
• W2783804430 hasConceptScore W2783804430C54173615 @default.

• next